EP1513397A4
Transgenic ungulates capable of human antibody production
Abstract
The invention features novel methods for the production of large quantities of xenogenous antibodies, such as human antibodies. Preferably, this result is effected by inactivation of IgM heavy chain expression and, optionally, by inactivation of Ig light chain expression, and by the further introduction of an artificial chromosome which results in the expression of xenogenous antibodies (e.g., non-bovine antibodies), preferably human antibodies.
Term
Term ended
Projected expiry passed 19 May 2023, 3.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both waysCites: the store holds 6 of 7
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO0135735A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 3-7,11 |
| WO02070648A2 | Cites | World Intellectual Property Organization (WIPO) | PX | Search report | 1-19,45 |
| EP0773288A2 | Cites | European Patent Office (EPO) | Y | Search report | 1-45 |
| WO0135735A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO02070648A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| EP0773288A | Cites | European Patent Office (EPO) | – | – | – |
| KUROIWA Y ET AL: "Cloned transchromosomic calves producing human immunoglobulin", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 20, no. 9, September 2002 (2002-09-01), pages 889 - 894, XP002976595, ISSN: 1087-0156 | Non-patent | – | – | Search report | – |
| ROBL JAMES M: "Application of cloning technology for production of human polyclonal antibodies in cattle", CLONING AND STEM CELLS, vol. 9, no. 1, April 2007 (2007-04-01), pages 12 - 16, XP002449218, ISSN: 1536-2302 | Non-patent | – | – | Search report | – |
| TOMIZUKA K ET AL: "FUNCTIONAL EXPRESSION AND GERMLINE TRANSMISSION OF A HUMAN CHROMOSOME FRAGMENT IN CHIMAERIC MICE", NATURE GENETICS, NEW YORK, NY, US, vol. 16, no. 2, 16 June 1997 (1997-06-16), pages 133 - 143, XP000770172, ISSN: 1061-4036 | Non-patent | – | – | Search report | – |
| CIBELLI J B ET AL: "CLONED TRANSGENIC CALVES PRODUCED FROM NONQUIESCENT FETAL FIBROBLASTS", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 280, 22 May 1998 (1998-05-22), pages 1256 - 1258, XP000786003, ISSN: 0036-8075 | Non-patent | – | – | Search report | – |
| KIKYO NOBUAKI ET AL: "Reprogramming nuclei: Insights from cloning, nuclear transfer and heterokaryons", JOURNAL OF CELL SCIENCE, CAMBRIDGE UNIVERSITY PRESS, LONDON, GB, vol. 113, no. 1, January 2000 (2000-01-01), pages 11 - 20, XP002176693, ISSN: 0021-9533 | Non-patent | – | – | Search report | – |
102 members in 16 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 381531P | United States of America | – | |
| 38153102 | United States of America | P | |
| 38153102 | United States of America | P | |
| 425056P | United States of America | – | |
| 42505602 | United States of America | P | |
| 42505602 | United States of America | P | |
| 0315937 | United States of America | W | |
| 0315937 | United States of America | W | |
| 381531P | – | – | – |
| 425056P | – | – | – |
| US20020381531P | – | – | – |
| US20020425056P | – | – | – |
| US2003015937 | – | – | – |
| WO2003US15937 | – | – | – |
Members102
| Document | Office | Kind | |
|---|---|---|---|
| WO0135735A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1777301A | Australia | A | |
| CA2427322A1 | Canada | A1 | |
| WO02051997A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CA2428053A1 | Canada | A1 | |
| WO02070648A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02070648A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003037347A1 | United States of America | A1 | |
| US2003046722A1 | United States of America | A1 | |
| US2003056237A1 | United States of America | A1 | |
| KR20030059260A | Republic of Korea | A | |
| EP1343880A2 | European Patent Office (EPO) | A2 | |
| KR20030082555A | Republic of Korea | A | |
| EP1356035A1 | European Patent Office (EPO) | A1 | |
| CA2484655A1 | Canada | A1 | |
| WO03097812A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003245300A1 | Australia | A1 | |
| WO03097812A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN1486365A | China | A | |
| US2004068760A1 | United States of America | A1 | |
| CN1498269A | China | A | |
| CA2502490A1 | Canada | A1 | |
| WO2004044156A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003290689A1 | Australia | A1 | |
| JP2004516835A | Japan | A | |
| EP1356035A4 | European Patent Office (EPO) | A4 | |
| WO2004044156A3 | World Intellectual Property Organization (WIPO) | A3 | |
| MXPA03005624A | Mexico | A | |
| KR20050000558A | Republic of Korea | A | |
| JP2005504507A | Japan | A | |
| HK1066028A | Hong Kong, China | A | |
| EP1343880A4 | European Patent Office (EPO) | A4 | |
| EP1513397A2 | European Patent Office (EPO) | A2 | |
| US2005097627A1 | United States of America | A1 | |
| NZ525607A | New Zealand | A | |
| EP1563084A2 | European Patent Office (EPO) | A2 | |
| US2005183145A1 | United States of America | A1 | |
| JP2005224250A | Japan | A | |
| BR0315300A | Brazil | A | |
| JP2005525817A | Japan | A | |
| CN1668187A | China | A | |
| KR20050093761A | Republic of Korea | A | |
| MXPA05004870A | Mexico | A | |
| IL165088A0 | Israel | A0 | |
| RU2005117629A | Russian Federation | A | |
| JP2006505291A | Japan | A | |
| CN1742088A | China | A | |
| EP1563084A4 | European Patent Office (EPO) | A4 | |
| US2006117394A1 | United States of America | A1 | |
| US2006117395A1 | United States of America | A1 | |
| US7074983B2 | United States of America | B2 | |
| JP3797974B2 | Japan | B2 | |
| US2006212952A1 | United States of America | A1 | |
| AU2002232858B2 | Australia | B2 | |
| AU2001297523B2 | Australia | B2 | |
| MXPA03004313A | Mexico | A | |
| AU2007201700A1 | Australia | A1 | |
| US7253334B2 | United States of America | B2 | |
| EP1513397A4This record | European Patent Office (EPO) | A4 | |
| KR20080005616A | Republic of Korea | A | |
| US2008040821A1 | United States of America | A1 | |
| KR100832943B1 | Republic of Korea | B1 | |
| NZ536341A | New Zealand | A | |
| US7414170B2 | United States of America | B2 | |
| NZ525664A | New Zealand | A | |
| US7429690B2 | United States of America | B2 | |
| CN100448991C | China | C | |
| KR100882029B1 | Republic of Korea | B1 | |
| KR100882030B1 | Republic of Korea | B1 | |
| US7491867B2 | United States of America | B2 | |
| NZ539459A | New Zealand | A | |
| EP2042594A1 | European Patent Office (EPO) | A1 | |
| EP1343880B1 | European Patent Office (EPO) | B1 | |
| AT432343T | Austria | T | |
| ATE432343T1 | Austria | T1 | |
| US2009165154A1 | United States of America | A1 | |
| DE60138832D1 | Germany | D1 | |
| CN100526460C | China | C | |
| US2009276866A1 | United States of America | A1 | |
| JP4420604B2 | Japan | B2 | |
| RU2384059C2 | Russian Federation | C2 | |
| EP1513397B1 | European Patent Office (EPO) | B1 | |
| AT464389T | Austria | T | |
| ATE464389T1 | Austria | T1 | |
| CN1486365B | China | B | |
| DE60332111D1 | Germany | D1 | |
| US7803981B2 | United States of America | B2 | |
| US7807863B2 | United States of America | B2 | |
| AU2010224312A1 | Australia | A1 | |
| US7820878B2 | United States of America | B2 | |
| IL206781A0 | Israel | A0 | |
| EP1356035B1 | European Patent Office (EPO) | B1 | |
| US2011067122A1 | United States of America | A1 | |
| EP2042594B1 | European Patent Office (EPO) | B1 | |
| AT502106T | Austria | T | |
| AT503012T | Austria | T | |
| ATE502106T1 | Austria | T1 | |
| ATE503012T1 | Austria | T1 | |
| DE60144248D1 | Germany | D1 | |
| DE60144305D1 | Germany | D1 |
Showing 100 of 102
81 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Notification of lapseLapsedST | ST | FR | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Discontinued in the netherlands as no translation has been filedVDEP | VDEP | NL | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deletedORIGINAL CODE: EPIDOSDIGR1GRAJ | GRAJ | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1513397
- Publication, DOCDB
- 1513397
- Publication, EPODOC
- EP1513397
- Application
- 3738939
- Application, DOCDB
- 03738939
- Application, EPODOC
- EP20030738939
Titles3
- German
- TRANSGENE HUFTIERE, DIE ZUR PRODUKTION VON MENSCHLICHEN ANTIKÖRPERN FÄHIG SIND
- English
- TRANSGENIC UNGULATES CAPABLE OF HUMAN ANTIBODY PRODUCTION
- French
- ONGULES TRANSGENIQUES CAPABLES DE PRODUIRE DES ANTICORPS HUMAINS
Classification
- CPC, 8
- A01K67/0275
- A01K67/027
- A01K2207/15
- A01K2217/00
- A01K2227/101
- A01K2267/01
- C12N15/8509
- C12N15/8773
- IPC, 13
- A01K67 027
- C12P21 00
- C12N
- C12N5 02
- C12N5 10
- C12N5 16
- C12N15 00
- C12N15 02
- C12N15 09
- C12N15 85
- C12N15 877
- C12P21 08
- C12N5 06
Designated states1
- Contracting states, 1
- Türkiye